Use of statins and risk of ovarian cancer: evidence on effect modification by parity, menopause and endometriosis from nationwide nested case-control studies

Meyya Bouazzi; Guoqiao Zheng; Jiangrong Wang; Louise Baandrup; Charlotte Gerd Hannibal; Rasmus Hertzum-Larsen; Rasmus Hertzum‐Larsen; Karin Sundström; Susanne K Kjaer; Susanne K. Kjær

doi:10.1016/j.ygyno.2025.05.008

Use of statins and risk of ovarian cancer: evidence on effect modification by parity, menopause and endometriosis from nationwide nested case-control studies

Meyya Bouazzi, Guoqiao Zheng, Jiangrong Wang, Louise Baandrup, Charlotte Gerd Hannibal, Rasmus Hertzum-Larsen, Rasmus Hertzum‐Larsen, Karin Sundström, Susanne K Kjaer, Susanne K. Kjær

Gynecologic oncology · 2025 · vol. 198 , pp. 130–136 · doi:10.1016/j.ygyno.2025.05.008 · PMID:40499207 · W4411169452

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex View on PubMed

⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This nationwide nested case-control study examined statin use and ovarian cancer risk, investigating potential modifications by parity, menopausal status, and endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors Hydroxymethylglutaryl-CoA Reductase Inhibitors

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (35)

History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer via openalex
Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank via openalex
W1993143598 via openalex
W1998436936 via openalex
W2059657958 via openalex
W2102067524 via openalex
W2114506441 via openalex
W2122985624 via openalex
W2144185116 via openalex
W2160208506 via openalex
W2168021466 via openalex
W2219591537 via openalex
W2233885014 via openalex
W2541013163 via openalex
W2787311961 via openalex
W2884148852 via openalex
W2886482717 via openalex
W2912205988 via openalex
W2934791458 via openalex
W2963330805 via openalex
W3008748669 via openalex
W3121692365 via openalex
W3163516959 via openalex
W3186447271 via openalex
W3207350175 via openalex
W3211625678 via openalex
W3214303045 via openalex
W4211203170 via openalex
W4225919223 via openalex
W4362520900 via openalex
W4391756276 via openalex
W4399209021 via openalex
W144464069 via openalex
W6804207707 via openalex
W1975472455 via openalex

SciLite annotations

chemicals 6

statin statin statin statin statin statin

Source provenance

europepmc: last seen: 2026-06-12T06:13:51.797165+00:00
openalex: last seen: 2026-06-04T00:00:01.174412+00:00
pubmed: last seen: 2026-05-20T00:31:22.508620+00:00
scilite: last seen: 2026-05-18T04:26:01.642840+00:00

License: CC0 · commercial use OK

[1] History of Endometriosis Is Independently Associated with an Increased Risk of Ovarian Cancer 2022

[2] Use of statins and risks of ovarian, uterine, and cervical diseases: a cohort study in the UK Biobank 2024